Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 509

    FDA Approves Mercks KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy

    FDA Approves Mercks KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy

    savita thakur thakur11 Aug 2016 1:03 PM IST
    Kenilworth : Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved...
    Eisai: FDA confirms enough data to move Alzheimers drug to Phase III studies

    Eisai: FDA confirms enough data to move Alzheimer's drug to Phase III studies

    savita thakur thakur10 Aug 2016 11:54 AM IST
    Japan's Eisai Co said the U.S. Food and Drug Administration had confirmed that there was sufficient data to start Phase III studies of a drug it is...
    Thousands of women took Sanofi epilepsy drug despite risk to fetuses: media

    Thousands of women took Sanofi epilepsy drug despite risk to fetuses: media

    savita thakur thakur10 Aug 2016 11:49 AM IST
    More than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was...
    USFDA bans import of drugs from Wockhardt’s Ankleshwar plant

    USFDA bans import of drugs from Wockhardt’s Ankleshwar plant

    savita thakur thakur10 Aug 2016 9:53 AM IST
    In yet another blow to drug maker Wockhardt, US Food and Drug Administration (USFDA) has banned import of products manufactured at its Ankleshwar...
    Glenmark gets USFDA nod for skin treatment cream

    Glenmark gets USFDA nod for skin treatment cream

    savita thakur thakur9 Aug 2016 12:25 PM IST
    New Delhi : Glenmark Pharmaceuticals has received final nod from the US health regulator for generic Triamcinolone acetonide cream used for reducing...
    Zydus acquires skin treatment lotion Melgain from Issar Pharma

    Zydus acquires skin treatment lotion Melgain from Issar Pharma

    savita thakur thakur9 Aug 2016 12:24 PM IST
    New Delhi : Zydus Group firm Cadila Healthcare said it has acquired Melgain lotion used for treatment of skin depigmentation from Issar Pharma to...
    Sun Pharma Extends Imatinib Mesylate Savings Card Program Benefits for Patients in USA

    Sun Pharma Extends Imatinib Mesylate Savings Card Program Benefits for Patients in USA

    savita thakur thakur9 Aug 2016 12:24 PM IST
    Mumbai : As part of the company’s philosophy of putting patients' interests first, Sun Pharma announced the extension of its Imatinib Mesylate...
    GM mosquito trial will not significantly impact environment: FDA

    GM mosquito trial will not significantly impact environment: FDA

    savita thakur thakur8 Aug 2016 12:38 PM IST
    The U.S. Food and Drug Administration said that a field trial testing Intrexon Corp's genetically engineered mosquitoes, meant to be used in the...
    AstraZeneca hits 2014 Pfizer bid price, helped by Bristols woes

    AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes

    savita thakur thakur8 Aug 2016 12:38 PM IST
    London : AstraZeneca shares hit a record high, breaching for the first time the 55 pounds a share level offered by Pfizer in 2014 during the U.S....
    Apollo Munich eyes 2-3 bancassurance tie-ups this fiscal

    Apollo Munich eyes 2-3 bancassurance tie-ups this fiscal

    savita thakur thakur8 Aug 2016 12:37 PM IST
    New Delhi : Enthused by the open architecture system announced by insurance regulator IRDAI, Apollo Munich Health Insurance said it is eyeing a couple...
    Novartis asthma pill shows promise in small trial

    Novartis asthma pill shows promise in small trial

    savita thakur thakur7 Aug 2016 12:08 PM IST
    The first new asthma pill in decades has produced promising results in a small clinical trial, potentially paving the way for another treatment option...
    Number of health insurance schemes to be enhanced

    Number of health insurance schemes to be enhanced

    savita thakur thakur7 Aug 2016 12:07 PM IST
    New Delhi : The Narendra Modi government is "conscious" of the need to provide universal health coverage and steps are being taken to increase the...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Google bets on European biotech drugs, backs new fund

    Google bets on European biotech drugs, backs new fund

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok